Exelixis Inc (EXEL)
33.29
-0.39
(-1.16%)
USD |
NASDAQ |
Dec 20, 16:00
33.29
0.00 (0.00%)
After-Hours: 20:00
Exelixis Market Cap: 9.507B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co Inc | 248.03B |
| ADMA Biologics Inc | 4.113B |
| Alnylam Pharmaceuticals Inc | 31.66B |
| Pfizer Inc | 149.38B |
| Sarepta Therapeutics Inc | 11.36B |
Market Cap Related Metrics
| PE Ratio | 21.34 |
| PS Ratio | 4.814 |
| PEG Ratio | 0.0473 |
| Price to Book Value | 4.178 |
| Price to Free Cash Flow | 24.75 |
| Price | 33.29 |
| Earnings Yield | 4.69% |
| PEGY Ratio | 0.0473 |
| Operating PE Ratio | 16.47 |
| Normalized PE Ratio | 18.72 |